ADIPOQ and metabolic syndrome: Adiponectin was initially identified as an insulin-sensitive adipose factor related to the pathogenesis of metabolic syndrome; over time, however, many studies have confirmed its anti-inflammatory, anti-apoptotic, anti-fibrotic, and anti-angiogenic effects (Bråkenhielm et al., 2004; Fang and Judd, 2018).